Literature DB >> 27884981

Tissue damage and senescence provide critical signals for cellular reprogramming in vivo.

Lluc Mosteiro1, Cristina Pantoja1, Noelia Alcazar1, Rosa M Marión2, Dafni Chondronasiou1, Miguel Rovira1, Pablo J Fernandez-Marcos1,3, Maribel Muñoz-Martin1, Carmen Blanco-Aparicio4, Joaquin Pastor4, Gonzalo Gómez-López5, Alba De Martino6, Maria A Blasco2, María Abad1,7, Manuel Serrano8.   

Abstract

Reprogramming of differentiated cells into pluripotent cells can occur in vivo, but the mechanisms involved remain to be elucidated. Senescence is a cellular response to damage, characterized by abundant production of cytokines and other secreted factors that, together with the recruitment of inflammatory cells, result in tissue remodeling. Here, we show that in vivo expression of the reprogramming factors OCT4, SOX2, KLF4, and cMYC (OSKM) in mice leads to senescence and reprogramming, both coexisting in close proximity. Genetic and pharmacological analyses indicate that OSKM-induced senescence requires the Ink4a/Arf locus and, through the production of the cytokine interleukin-6, creates a permissive tissue environment for in vivo reprogramming. Biological conditions linked to senescence, such as tissue injury or aging, favor in vivo reprogramming by OSKM. These observations may be relevant for tissue repair.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27884981     DOI: 10.1126/science.aaf4445

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  201 in total

Review 1.  Cellular Senescence: The Trojan Horse in Chronic Lung Diseases.

Authors:  Shruthi Hamsanathan; Jonathan K Alder; Jacobo Sellares; Mauricio Rojas; Aditi U Gurkar; Ana L Mora
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

2.  Senescent Breast Luminal Cells Promote Carcinogenesis through Interleukin-8-Dependent Activation of Stromal Fibroblasts.

Authors:  Huda H Al-Khalaf; Hazem Ghebeh; Rabia Inass; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2019-01-03       Impact factor: 4.272

3.  Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.

Authors:  Ana L Mora; Mauricio Rojas; Annie Pardo; Moises Selman
Journal:  Nat Rev Drug Discov       Date:  2017-10-30       Impact factor: 84.694

Review 4.  Rejuvenating Strategies for Stem Cell-Based Therapies in Aging.

Authors:  Joana Neves; Pedro Sousa-Victor; Heinrich Jasper
Journal:  Cell Stem Cell       Date:  2017-02-02       Impact factor: 24.633

5.  Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells.

Authors:  Izumi Horikawa; Kye-Yoon Park; Kazunobu Isogaya; Yukiharu Hiyoshi; Han Li; Katsuhiro Anami; Ana I Robles; Abdul M Mondal; Kaori Fujita; Manuel Serrano; Curtis C Harris
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

6.  Cellular senescence: Senescence and reprogramming go hand-in-hand.

Authors:  Kim Baumann
Journal:  Nat Rev Mol Cell Biol       Date:  2016-12-19       Impact factor: 94.444

Review 7.  Metastatic niche functions and therapeutic opportunities.

Authors:  Toni Celià-Terrassa; Yibin Kang
Journal:  Nat Cell Biol       Date:  2018-07-26       Impact factor: 28.824

Review 8.  Circulating miRNAs and miRNA shuttles as biomarkers: Perspective trajectories of healthy and unhealthy aging.

Authors:  Fabiola Olivieri; Miriam Capri; Massimiliano Bonafè; Cristina Morsiani; Hwa Jin Jung; Liana Spazzafumo; Jose Viña; Yousin Suh
Journal:  Mech Ageing Dev       Date:  2016-12-13       Impact factor: 5.432

Review 9.  Senescent cells: an emerging target for diseases of ageing.

Authors:  Bennett G Childs; Martina Gluscevic; Darren J Baker; Remi-Martin Laberge; Dan Marquess; Jamie Dananberg; Jan M van Deursen
Journal:  Nat Rev Drug Discov       Date:  2017-07-21       Impact factor: 84.694

10.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.